About: Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.14 (+4.59%)
XCUR NASDAQ Exicure Inc
Loading watchlist status…
Exicure Inc share price
XCUR price activity
Last Price
$1.140
Change (24hr)
0.05 USD (4.59%)
Volume
17.45K
Volume (4w avg)
-
Open
$1.12
Day Range
$1.12 - $1.14
Previous Close
$1.09
Last Trade
13 Oct, 6:37 pm GMT+0
Delayed
13 Oct, 6:37 pm GMT+0
XCUR price performance
5.56%
5D
-18.57%
1M
-78.97%
YTD
-77.82%
1Y
Delayed
13 Oct, 6:37 pm GMT+0
XCUR Market Signals